Silicon Valley's most anticipated slide deck just dropped. What does it mean for biopharma's digital teams?
These aren’t the typical slides you’d see at Endpoints — no molecules, clinical programs, or p-values. Instead, we’ll talk digital and internet trends, factors that elite global brands — regardless of industry — must first measure and understand before deploying products into the world. That’s a concept that most of our Big Pharma audience is in tune with. Digital awareness is key to success in the discovery, development, and marketing of new biopharmaceuticals, and most of the majors now have a chief digital officer: Novartis, Sanofi, and Pfizer, just to name a few.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.
